News
Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...
Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...
In this strange new world where a weekly injection can quickly achieve what years of attempted diets may fail to do, the ...
Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The ...
8h
GlobalData on MSNMounjaro and Zepbound fuel strong Q2 growth for Eli Lilly
Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...
Sales of Novo Nordisk's Wegovy and Eli Lilly's Mounjaro in India doubled in July, according to Pharmarack data. Wegovy, ...
Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster ...
Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...
Users of weight loss drugs such as Wegovy and Mounjaro, along with those who use type 2 diabetes drug Ozempic for weight loss ...
First ever daily Ozempic-like PILL helps users shed up to 2st – and could be available within months
A DAILY weight loss pill that works like Ozempic can help users shed an average of almost two stone, a study reveals. People ...
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...
You might have seen people talking about a 'golden dose' on social media in regards to weight loss jabs, but what exactly is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results